nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II trial of ZD0473 in platinum-pretreated ovarian cancer
|
Gore, M.E. |
|
2002 |
38 |
18 |
p. 2416-2420 5 p. |
artikel |
2 |
Author Index
|
|
|
2002 |
38 |
18 |
p. 2518-2524 7 p. |
artikel |
3 |
Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used
|
Del Bufalo, D |
|
2002 |
38 |
18 |
p. 2455-2462 8 p. |
artikel |
4 |
Calendar
|
|
|
2002 |
38 |
18 |
p. I-II nvt p. |
artikel |
5 |
Cancer risks in Nordic immigrants and their offspring in Sweden
|
Hemminki, K |
|
2002 |
38 |
18 |
p. 2428-2434 7 p. |
artikel |
6 |
Comments on article by C. Sternberg
|
Hoskin, P.J |
|
2002 |
38 |
18 |
p. 2476- 1 p. |
artikel |
7 |
Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest
|
Murillo, G |
|
2002 |
38 |
18 |
p. 2446-2454 9 p. |
artikel |
8 |
Editorial Board
|
|
|
2002 |
38 |
18 |
p. ii- 1 p. |
artikel |
9 |
EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)—chemotherapy selected for multidrug resistance modulation
|
Davidson, A |
|
2002 |
38 |
18 |
p. 2422-2427 6 p. |
artikel |
10 |
Focal liver lesions in non-Hodgkin's lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection
|
Civardi, G |
|
2002 |
38 |
18 |
p. 2382-2387 6 p. |
artikel |
11 |
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression
|
Ioachim, E |
|
2002 |
38 |
18 |
p. 2362-2370 9 p. |
artikel |
12 |
Maintenance of PtdIns45P2 pools under limiting inositol conditions, as assessed by liquid chromatography–tandem mass spectrometry and PtdIns45P2 mass evaluation in Ras-transformed cells
|
Berrie, C.P. |
|
2002 |
38 |
18 |
p. 2463-2475 13 p. |
artikel |
13 |
MDR1 inhibition: less resistance or less relevance?
|
Garraway, L.A |
|
2002 |
38 |
18 |
p. 2337-2340 4 p. |
artikel |
14 |
Mixed response
|
|
|
2002 |
38 |
18 |
p. ix-x nvt p. |
artikel |
15 |
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate
|
Engel, J |
|
2002 |
38 |
18 |
p. 2435-2445 11 p. |
artikel |
16 |
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours
|
de Jonge, M.J.A. |
|
2002 |
38 |
18 |
p. 2407-2415 9 p. |
artikel |
17 |
Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule
|
Sessa, C. |
|
2002 |
38 |
18 |
p. 2388-2396 9 p. |
artikel |
18 |
Prescribing anti-cancer drugs in elderly cancer patients
|
Monfardini, Silvio |
|
2002 |
38 |
18 |
p. 2341-2346 6 p. |
artikel |
19 |
Referees—2002
|
|
|
2002 |
38 |
18 |
p. 2477- 1 p. |
artikel |
20 |
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
|
van Oosterom, A.T |
|
2002 |
38 |
18 |
p. 2397-2406 10 p. |
artikel |
21 |
Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients
|
Terashima, M |
|
2002 |
38 |
18 |
p. 2375-2381 7 p. |
artikel |
22 |
Survival statistics "overly pessimistic"
|
|
|
2002 |
38 |
18 |
p. 2331-2335 5 p. |
artikel |
23 |
The role of new agents in the treatment of non-small cell lung cancer
|
Bröker, Linda E |
|
2002 |
38 |
18 |
p. 2347-2361 15 p. |
artikel |
24 |
The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer
|
Sauven, P |
|
2002 |
38 |
18 |
p. 2371-2374 4 p. |
artikel |